Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 32.80
-0.15 (-0.46%)
Nov 6, 2026, 1:02 PM CST
Sofiva Genomics Market Cap
Sofiva Genomics has a market cap or net worth of 708.26 million as of November 6, 2026. It is the 36,075th most valuable company in the world and the 2,158th biggest in Taiwan. Its market cap has increased by 6.84% in one year.
Market Cap
708.26M
Enterprise Value
614.79M
Revenue
379.21M
Global Rank
Country Rank
#2,158 Taiwan
PE Ratio
102.43
ChartMarket Cap Chart
Since January 5, 2017, Sofiva Genomics's market cap has decreased from 1.70B to 708.26M, a decrease of -58.31%. That is a compound annual growth rate of -8.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 708.26M | 8.79% |
| Dec 31, 2025 | 651.04M | -24.53% |
| Dec 31, 2024 | 862.66M | -1.51% |
| Dec 29, 2023 | 875.86M | 11.72% |
| Dec 30, 2022 | 784.00M | -24.75% |
| Dec 30, 2021 | 1.04B | -4.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.29B |
| DIVA Laboratories | 1.77B |
| Puriblood Medical | 1.01B |
| Genetics Generation Advancement | 935.66M |
| Kim Forest Enterprise | 769.90M |
| TFBS Bioscience | 614.93M |
| Pharmigene | 406.24M |
| Welgene Biotech | 376.36M |